Bio-Techne
Large Cap · Healthcare · Biotechnology
$72.23−$0.16 (-0.22%)
Bio-Techne
Large Cap · Healthcare · Biotechnology
$72.23−$0.16 (-0.22%)
Stock analysis
Get the AI take on TECH
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$43.20
High$72.37
Today $72.23
RSI (14)
56.9Neutral
03070100
Overall score
41/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Lowest
$50
Current price
$72.23
Highest
$73
Median target
$73
LowHigh
Operating Record
Revenue
What's working
- Debt / equity: Light borrowing means a rough patch wouldn't threaten the balance sheet.
- Current ratio: What's on hand comfortably covers the bills due over the next year.
What to watch
- Debt exceeds cash by $24.4M, increasing balance-sheet pressure, a warning sign.
- Forward P/E: The price already assumes strong earnings growth that still has to show up.
What the market charges
Forward P/E
Needs attention · 88% above avg
35.38x
Price / sales
Rich · Priced well above what its revenue alone supports
9.29x
Price / FCF
Rich · Priced far above what its cash flow currently supports
42.86x
EV / EBITDA
Rich · Operating earnings don't yet support this price
31.84x
How efficiently it compounds
ROIC
Reasonable · A middling return on the capital it puts to work
9.1%
ROE
Needs attention · Unfavorable
9.0%
Debt / equity
Favorable · 0.14 - strong leverage
0.14x
Current ratio
Strong · Comfortable room to cover bills due within a year
4.55x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $11.34B | 62.5 | -0.4% | 41 |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |